Novartis





Ebitda Veränderung Datum
AbbVie USD 3.52B 828M 2025-09
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.23B 272M 2025-09
Bausch Health Companies USD 986M 74M 2025-09
Biogen USD 573.2M 253.7M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Canopy Growth CAD 16.62M 38.45M 2025-09
Corcept Therapeutics USD 27.14M 23.27M 2025-06
Drreddys Laboratories INR 21.59B 1.49B 2025-12
Eli Lilly USD 7.88B 378.1M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Glaxosmithkline GBP 4.75B 1.52B 2025-09
J&J USD 9.52B 389M 2025-09
Merck USD 8.39B 1.97B 2025-09
Novartis USD 5.88B 290M 2025-09
Novartis USD 5.84B 235M 2025-09
Pacira USD 49.36M 4.96M 2025-09
Perrigo USD 258.8M 37.3M 2025-09
Pfizer USD 6.08B 351M 2025-09
Phibro Animal Health USD 30.48M 1.1M 2024-09
Prestige Brands USD 90.82M 3.99M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.84B 2.95B 2025-09
Sanofi EUR 5.66B 3.77B 2025-09
Supernus Pharmaceuticals USD 41.9M 432K 2025-09
Zoetis USD 1.04B 87M 2025-09


Novartis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.